日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Publisher Correction: SLC2A1(+) tumour-associated macrophages spatially control CD8(+) T cell function and drive resistance to immunotherapy in non-small-cell lung cancer

出版商更正:SLC2A1(+)肿瘤相关巨噬细胞在空间上调控CD8(+) T细胞功能,并驱动非小细胞肺癌对免疫疗法的耐药性

Wang, Lei; Chu, Han; Chen, Degao; Wei, Yuxuan; Jia, Jia; Li, Liqi; He, Linfeng; Peng, Lina; Liu, Fangfang; Huang, Shanshan; Jin, Zheng; Zhou, Dong; Fang, WenFeng; Jiang, Tao; Xu, Shouxia; Ding, Xiaofang; Cai, Haoyang; Liu, Xindong; Jia, Qingzhu; Zhu, Bo; Chu, Qian

SLC2A1(+) tumour-associated macrophages spatially control CD8(+) T cell function and drive resistance to immunotherapy in non-small-cell lung cancer

SLC2A1(+)肿瘤相关巨噬细胞在空间上调控CD8(+) T细胞功能,并驱动非小细胞肺癌对免疫疗法的耐药性。

Wang, Lei; Chu, Han; Chen, Degao; Wei, Yuxuan; Jia, Jia; Li, Liqi; He, Linfeng; Peng, Lina; Liu, Fangfang; Huang, Shanshan; Jin, Zheng; Zhou, Dong; Fang, WenFeng; Jiang, Tao; Xu, Shouxia; Ding, Xiaofang; Cai, Haoyang; Liu, Xindong; Jia, Qingzhu; Zhu, Bo; Chu, Qian

Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16-CXCR6 signaling for potent antitumor response.

靶向 STING、TGF-β 和 PD-L1 的三重靶向作用可增强 CXCL16-CXCR6 信号传导,从而产生强大的抗肿瘤反应。

Yi Ming, Li Tianye, Gu Yinhui, Niu Mengke, Xue Dixuan, Hu Shengtao, Wu Yuze, Zhao Bin, Zhang Di, Ma Yingkang, Zhang Minjun, Zhang Jing, Yan Yongxiang, Zhou Pengfei, Zhang Xiaojun, Zhou Zhuxian, Chu Qian, Wu Kongming, Dai Zhijun

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites.

PARPi 结合纳米颗粒 LIN28B siRNA 用于治疗恶性腹水。

Fang Yan, Shen Qian, Lin Yao, Zhu Jing, Zhu Xiaolan, Huang Rui, Wu Yijia, Shen Feiyang, Li Qian, Zheng Guopei, Zhang Zhe, Chu Qian, Hu Junhao, Shen Jianfeng

Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models

在KRAS突变癌症模型中,联合靶向DNA拓扑异构酶II可增强RAS靶向治疗的疗效。

Xu, Rongzhong; Wang, Dongsheng; Ma, Guangzhi; Yuan, Xun; Chu, Qian; Fan, Songqing; Zhang, Rener; Du, Pan; Jia, Shidong; Leal, Ticiana A; Ramalingam, Suresh S; Chen, Zhen; Sun, Shi-Yong

Expert consensus on the detection and clinical application of tumor mutational burden

关于肿瘤突变负荷的检测和临床应用的专家共识

Guo, Zhenying; Xu, Chunwei; Zhang, Shirong; Hao, Yue; Hu, Xiaotong; Zhao, Ming; Xiang, Chan; Piao, Yingshi; Sun, Pingli; Xiang, Xueping; Zhao, Jing; Wu, Huanwen; Li, Weixing; Yu, Jinpu; Yuan, Jingping; Wang, Shuangshuang; Wang, Cong; Gu, Yun; Lv, Bingjian; Zhang, Liping; Liu, Yueping; Cui, Xiaobin; Gu, Weizhong; Li, Yining; Wang, Wei; Yang, Wenjun; Long, Weiguo; Xiang, Jingjing; Mou, Hong; Liu, Biao; Ruan, Huajuan; Wang, Yubin; Zhu, Yongjie; Wang, Feng; Wang, Zhonghua; Feng, Xiaomin; Liu, Xing; Li, Peng; Deng, Min; Lian, Bin; Mao, Lili; Wang, Qian; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Zhong, Wenzhao; Wang, Zhijie; Ren, Shengxiang; Fang, Wenfeng; Zhang, Yongchang; Liu, Jingjing; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Zhang, Yu; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Shen, Peng; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Ge, Rui; Dai, Enyong; Han, Yu; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Liu, Xuewen; Yao, Yu; Luo, Peng; Pan, Weiwei; Pang, Fei; Wu, Fan; Gu, Dejian; Wang, Li; Wang, Liping; Zhu, Youcai; Lin, Li; Li, Weiwen; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Ji, Qing; Fang, Yuan; Wei, Qing; Wang, Zhen; Wan, Bin; Lv, Donglai; Li, Xiaofeng; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Zhongwu; Li, Miao; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Si, Lu; Song, Yong; Lu, Yuanzhi; Liu, Aijun; Han, Yuchen

Noninvasive prediction of occult pT3a upstaging in localized ccRCC with radiogenomic insights and prognostic relevance

利用放射基因组学见解和预后相关性,对局限性透明细胞肾细胞癌中隐匿性pT3a分期升级进行无创预测

Li, Shichao; Wang, Chuhuai; Li, Feng; Gao, Mengmeng; He, Kangwen; Zhou, Ziling; Qu, Weinuo; Shen, Yaqi; Chu, Qian; Wu, Shan; Qu, Jinrong; Zhang, Yudong; Li, Zhen

Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities

肺癌免疫微环境中的细胞衰老及其治疗契机

Xu, Zhaolin; Liu, Fangfang; Huang, Shanshan; Chu, Qian

Peptides as multifunctional linchpins in targeted drug conjugates

肽作为靶向药物偶联物的多功能关键分子

Li, Xue; Qian, Yuechen; Cheng, Jiongjia; Chu, Qian